Improved Outcomes in Bone Marrow Transplant (BMT) Patients through Standardization of Practices Related to the Use of Central Venous Catheters

被引：0
|
作者：
Simpson, E. T. [1 ]
Briggs, A. D. [1 ]
Gibson, D. [1 ]
Kendrick, S. [1 ]
Schriber, J. R. [1 ]
机构：
[1] Virginia G Piper Canc Ctr, Canc Transplant Inst, Scottsdale, AZ USA
来源：
TRANSFUSION | 2013年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：271A / 271A
页数：1
相关论文
共 38 条
  • [31] Hemolytic anemia (HA) is a common and treatable manifestation of chronic graft versus host disease (cGvHD) in patients (PTS) post partially mismatched related donor (PMRD) bone marrow transplant (BMT).
    Godder, K
    Pati, AR
    Abhyankar, S
    Lamb, L
    Gee, AP
    HensleeDowney, PJ
    BLOOD, 1995, 86 (10) : 1564 - 1564
  • [32] AVOIDANCE OF BOTH SEVERE ACUTE AND CHRONIC GRAFT VERSUS HOST-DISEASE (GVHD) FOLLOWING RELATED HAPLOTYPE MISMATCHED BONE-MARROW TRANSPLANT (BMT) FOR PATIENTS (PTS) WITH FAR ADVANCED LEUKEMIA
    HENSLEEDOWNEY, PJ
    BISHOP, MR
    GYARFAS, J
    ROMOND, EH
    CIOCCI, GH
    YANKEY, RD
    MARCINIAK, E
    THOMPSON, JS
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 715 - 715
  • [33] Outcomes of one human leukocyte antigen (HLA) mismatched related allogeneic bone marrow transplantation (BMT) in consecutive patients compared to fully HLA matched control patients transplanted during the same time period
    Kiss, TL
    Lipton, J
    Messner, HA
    BLOOD, 1998, 92 (10) : 288A - 289A
  • [34] CENTRAL VENOUS CATHETER-RELATED INFECTIONS AFTER BONE-MARROW TRANSPLANTATION IN PATIENTS WITH MALIGNANCIES - A PROSPECTIVE-STUDY WITH SHORT-COURSE VANCOMYCIN PROPHYLAXIS
    VASSILOMANOLAKIS, M
    PLATANIOTIS, G
    KOUMAKIS, G
    HAJICHRISTOU, H
    SKOUTERI, H
    DOVA, H
    EFREMIDIS, AP
    BONE MARROW TRANSPLANTATION, 1995, 15 (01) : 77 - 80
  • [35] Comparison of two different time interval protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized, multicenter study (vol 85, pg 275, 2000)
    Rasero
    HAEMATOLOGICA, 2000, 85 (05) : 560 - 560
  • [36] Graft-Versus-Host Disease (GVHD) and Survival Outcomes after HLA-Haploidentical (Haplo) Bone Marrow Transplant (BMT) Compare Favorably with Matched Related Donor (MRD), and Matched Unrelated Donor (MUD) BMT Utilizing High-Dose Posttransplantation Cyclophosphamide (PTCy)
    McCurdy, Shannon R.
    Kanakry, Christopher G.
    Kasamon, Yvette L.
    Meade, Javier Bolanos
    Tsai, Hua-Ling
    Showel, Margaret M.
    Kanakry, Jennifer A.
    Symons, Heather J.
    Rosner, Gary L.
    Fuchs, Ephraim J.
    Jones, Richard J.
    Luznik, Leo
    BLOOD, 2014, 124 (21)
  • [37] Survival after allogeneic bone marrow transplant (BMT) for adult acute lymphoblastic leukemia (ALL) is the same whether patients received either matched related donor (MRD) or matched unrelated donor (MUD) grafts.
    Absi, A
    Bolwell, BJ
    Sobecks, R
    Pohlman, B
    Andresen, S
    Rybicki, L
    Kalaycio, M
    BLOOD, 2003, 102 (11) : 490A - 490A
  • [38] Improved Clinical Outcomes of High Risk β Thalassemia Major Patients Under Going a HLA Matched Related Allogeneic Stem Cell Transplant with the Use of a Treosulphan Based Conditioning Regimen and Peripheral. Blood Stem Cell Grafts
    Mathews, Vikram
    George, Biju
    Lakshmi, Kavitha M.
    Abraham, Aby
    Ahmed, Rayaz
    Viswabandhya, Auro
    Srivastava, Alok
    BLOOD, 2011, 118 (21) : 466 - 466
1234